These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25957032)

  • 21. Evaluation of Response to Preoperative Chemotherapy Versus Surgery Alone in Gastroesophageal Cancer: Tumor Resectability, Pathologic Results and Post-Operative Complications.
    Kashefi Marandi A; Shojaiefard A; Soroush A; Ghorbani Abdegah A; Jafari M; Khodadost M; Mahmoudzade H
    Asian Pac J Cancer Prev; 2016; 17 Spec No.():231-7. PubMed ID: 27165231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome.
    Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
    Ann Surg; 2007 Jul; 246(1):1-8. PubMed ID: 17592282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
    Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
    J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postoperative complications after esophagectomy for adenocarcinoma of the esophagus are related to timing of death due to recurrence.
    Lagarde SM; de Boer JD; ten Kate FJ; Busch OR; Obertop H; van Lanschot JJ
    Ann Surg; 2008 Jan; 247(1):71-6. PubMed ID: 18156925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
    Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thymidylate synthase protein expression: Association with response to neoadjuvant chemotherapy and resection for locally advanced gastric and gastroesophageal adenocarcinoma.
    Alexander HR; Grem JL; Hamilton JM; Pass HI; Hong M; Fraker DL; Steinberg SM; McAtee N; Allegra BC; Johnston PG
    Cancer J Sci Am; 1995; 1(1):49-54. PubMed ID: 9166454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction.
    Barbour AP; Rizk NP; Gerdes H; Bains MS; Rusch VW; Brennan MF; Coit DG
    J Am Coll Surg; 2007 Oct; 205(4):593-601. PubMed ID: 17903735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controversies and Consensus in Preoperative Therapy of Esophageal and Gastroesophageal Junction Cancers.
    Ku GY
    Surg Oncol Clin N Am; 2017 Apr; 26(2):241-256. PubMed ID: 28279467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer of the gastroesophageal junction: combined modality therapy.
    Ilson DH
    Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adenocarcinoma of the esophagogastric junction: retrospective analysis of 39 patients].
    Butte JM; Becker F; Visscher A; Waugh E; Meneses M; Court I; Parada H; DE LA Fuente H
    Rev Med Chil; 2010 Jan; 138(1):53-60. PubMed ID: 20361151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus.
    Leers JM; DeMeester SR; Chan N; Ayazi S; Oezcelik A; Abate E; Banki F; Lipham JC; Hagen JA; DeMeester TR
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):594-602; discussion 601-2. PubMed ID: 19698841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity.
    Rice DC; Correa AM; Vaporciyan AA; Sodhi N; Smythe WR; Swisher SG; Walsh GL; Putnam JB; Komaki R; Ajani JA; Roth JA
    Ann Thorac Surg; 2005 Feb; 79(2):391-7; discussionn 391-7. PubMed ID: 15680801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis.
    Plum PS; Damanakis A; Buschmann L; Ernst A; Datta RR; Schiffmann LM; Zander T; Fuchs H; Chon SH; Alakus H; Schröder W; Hölscher AH; Bruns CJ; Bludau M
    J Cancer Res Clin Oncol; 2022 May; 148(5):1223-1234. PubMed ID: 34223965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Understanding and controversy of the gastroesophageal junction adenocarcinoma].
    Zhang XH; Wang QZ
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):947-9. PubMed ID: 19174001
    [No Abstract]   [Full Text] [Related]  

  • 35. Benefit of neoadjuvant chemotherapy for Siewert type II esophagogastric junction adenocarcinoma.
    Hosoda K; Yamashita K; Katada N; Moriya H; Mieno H; Sakuramoto S; Kikuchi S; Watanabe M
    Anticancer Res; 2015 Jan; 35(1):419-25. PubMed ID: 25550582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical factors influence the outcome after Ivor-Lewis esophagectomy with intrathoracic anastomosis for adenocarcinoma of the esophagogastric junction: a consecutive series of 240 patients at an experienced center.
    Ott K; Bader FG; Lordick F; Feith M; Bartels H; Siewert JR
    Ann Surg Oncol; 2009 Apr; 16(4):1017-25. PubMed ID: 19189186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of Gastroesophageal Junction Tumors.
    Okereke IC
    Surg Clin North Am; 2017 Apr; 97(2):265-275. PubMed ID: 28325186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of anemia in patients receiving neoadjuvant chemotherapy for locally advanced esophagogastric cancer.
    Voelter V; Schuhmacher C; Busch R; Peschel C; Siewert JR; Lordick F
    Ann Thorac Surg; 2004 Sep; 78(3):1037-41. PubMed ID: 15337044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
    Malaisrie SC; Untch B; Aranha GV; Mohideen N; Hantel A; Pickleman J
    Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.
    Stiles BM; Mirza F; Coppolino A; Port JL; Lee PC; Paul S; Altorki NK
    Ann Thorac Surg; 2011 Aug; 92(2):491-6; discussion 496-8. PubMed ID: 21704291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.